Overview
- Children’s Wisconsin and UW Health confirmed they have paused prescribing puberty blockers and cross-sex hormones for patients under 18.
- Children’s Wisconsin attributed the move to escalating legal and federal regulatory risk and said it is currently unable to provide gender-affirming pharmacologic care.
- UW Health said the pause follows recent federal actions and emphasized its commitment to high-quality, patient-centered care for LGBTQ+ patients.
- In December, HHS announced proposed rules that would deny Medicare and Medicaid funding to hospitals providing gender-affirming care to minors.
- Fitchburg Family Pharmacy said it will continue prescribing and dispensing these medications, drawing praise from some advocates and criticism from Republican Rep. Tom Tiffany as Democratic Rep. Francesca Hong urged hospitals to reconsider.